Found: 21
Select item for more details and to access through your institution.
Novel Treatment Approaches for Patients with Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 6, n. 4, p. 281
- By:
- Publication type:
- Article
Capital in 21st Century.
- Published in:
- 2015
- By:
- Publication type:
- Book Review
Outcomes following watchful waiting for stage II- IV follicular lymphoma patients in the modern era.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 5, p. 724, doi. 10.1111/bjh.13895
- By:
- Publication type:
- Article
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 539, doi. 10.1111/bjh.13637
- By:
- Publication type:
- Article
A curious ulcer on the pinna: rhinosporidiosis at an unusual place.
- Published in:
- International Journal of Dermatology, 2015, v. 54, n. 7, p. e277, doi. 10.1111/ijd.12817
- By:
- Publication type:
- Article
Vinorelbine, Paclitaxel, Etoposide, Cisplatin, and Cytarabine (VTEPA) Is an Effective Second Salvage Therapy for Relapsed/Refractory Hodgkin Lymphoma.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Racial Differences in the Presentation and Outcomes of Chronic Lymphocytic Leukemia and Variants in the United States.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 6, p. 498, doi. 10.1016/j.clml.2011.07.002
- By:
- Publication type:
- Article
Hepatitis C Reactivation in Patients Who Have Diffuse Large B-Cell Lymphoma Treated With Rituximab: A Case Report and Review of Literature.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 5, p. 379, doi. 10.1016/j.clml.2011.04.005
- By:
- Publication type:
- Article
Surveillance Computed Tomography Scans for Patients With Lymphoma: Is the Risk Worth the Benefits?
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 4, p. 270, doi. 10.3816/CLML.2010.n.056
- By:
- Publication type:
- Article
Clinical, molecular, and environmental risk factors for hodgkin lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Clinical, Molecular, and Environmental Risk Factors for Hodgkin Lymphoma.
- Published in:
- Advances in Hematology, 2011, v. 2011, p. 1, doi. 10.1155/2011/736261
- By:
- Publication type:
- Article
Novel treatment approaches for patients with relapsed and refractory multiple myeloma.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2012, v. 2, p. 87, doi. 10.2147/BLCTT.S18701
- By:
- Publication type:
- Article
A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Combination of GM-CSF With Fludarabine-Containing Regimens in Chronic Lymphocytic Leukemia and Indolent Non-Hodgkin Lymphoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma.
- Published in:
- ISRN Hematology, 2011, p. 1, doi. 10.5402/2011/623924
- By:
- Publication type:
- Article
Development of the Lymphoma Enterprise Architecture Database: A caBIG Silver Level Compliant System.
- Published in:
- Cancer Informatics, 2009, n. 7, p. 45
- By:
- Publication type:
- Article
The use and effectiveness of rituximab maintenance in patients with follicular lymphoma diagnosed between 2004 and 2007 in the United States.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 12, p. 1830, doi. 10.1002/cncr.28659
- By:
- Publication type:
- Article
A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 14, p. 3538, doi. 10.1002/cncr.26660
- By:
- Publication type:
- Article
Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 11, p. 2530, doi. 10.1002/cncr.25765
- By:
- Publication type:
- Article
Improving Outcomes for Patients with Diffuse Large B-cell Lymphoma.
- Published in:
- CA: A Cancer Journal for Clinicians, 2010, v. 60, n. 6, p. 393, doi. 10.3322/caac.20087
- By:
- Publication type:
- Article